Continuous-filament glass fibers coated with organic agents, candidate asbestos substitutes, were assessed for their ability to elicit from normal human serum complement-derived cleavage products which are able to stimulate the chemotaxis and the respiratory burst of polymorphonuclear leukocytes. Glass fibers generated chemoattracting and respiratory stimulating factors for polymorphonuclears from human serum. The effect was dose related for chemotaxis from the serum fiber concentration of 75 μg/ml to 1,250 μg/ml. The serum chemoattracting activity, as well the respiratory stimulation, were dramatically impaired when serum had been preliminarily absorbed with antiC5 antiserum. Since the impairment of chemotactic activity occurred also in the presence of EDTA, but not in the presence of EGTA, we assumed an activation of the alternative complement pathway.
Glass fibers were studied in comparison to a UICC sample of Canadian chrysotile asbestos, which is able to activate in vitro the alternative complement pathway.
Glass fibers exhibited less ability than asbestos fibers to generate complement cleavage products with chemotactic activity for polymorphonuclears; however, they produced an activity about equal to 80% of a chemotactic standard stimulus such as zymosan-activated plasma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- AF:
-
asbestos fibers
- antiCS-abs-S:
-
NHS absorbed with antiserum against C5
- EDTA-CH-S:
-
NHS treated with EDTA
- EGTA-Ch-S:
-
NHS treated with EGTA
- GF:
-
continuous filament glass fibers coated with a binder of organic substances
- NHP:
-
normal human plasma
- NHS:
-
normal human serum
- PMN:
-
polymorphonuclear luekocytes
- ZAP:
-
zymosan-activated plasma
References
BECKLAKE, M.R. (1982). Asbestos-related diseases of the lungs and pleura. Am. Rev. Respir. Dis. 126:187–194.
BRODY, A.R., HILL, L.H., ADKINS, B. and O'CONNOR, R.W. (1981). Chrysotile asbestos inhalation in rats: Deposition pattern and reaction of alveolar epithelium and pulmonary macrophages. Am. Rev. Respir. Dis. 123:670–679.
BURGER, R., BITTER-SUERMANN, D., LOOS, M. and HADDING, U. (1977). Insoluble polyanions as activators of both pathways of complement. Immunology 33:827–837.
CALLIS, A.H., SOHNLE, P.G., MANDEL, G.S. and MANDEL, N.S. (1986). The role of complement in experimental silicosis. Environm. Res. 40:301–312.
CAMPBELL, D.H., GARVEY, J.S., CREMER, N.E. and SUSSDORF, D.H. (1970). Methods in Immunology, pp. 28–30, W.A. Benjamin, Inc., New York.
COLDITZ, I.G. and MOVAT, H.Z. (1984). Kinetics of neutrophil accumulation in acute inflammatory lesions induced by chemotaxins and chemotaxinigens. J. Immunol. 133:2169–2173.
CRADDOK, P.R., FEHR, J., DALMASSO, A.P., BRIGHAM, K.L. and JACOB, H.S. (1977). Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J. Clin. Invest. 39:879–888.
CRAIGHEAD, J.E., ABRAHAM, J.L., CHURG, A., GREEN, F.H.Y., KLEINERNMAN, J., PRATT, P.C., SEEMAYER, T.A., VALLYATHAN, V. and WEILL, H. (1982). Asbestos-associated diseases. Arch. Pathol. Lab. Med. 106:542–596.
DAVIS, J.M.G. (1986). A review of experimental evidence for the carcinogenicity of man-made vitreous fibers. Scan. J. Work Environ. Health 12(Suppl.1):12–17.
FERRANTE, A. and THONG, Y.H. (1980). Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leukocytes from human peripheral blood by the Hypaque-Ficoll method. J. Immunol. Methods 36:109–117.
FINE, D.P., MARNEY, S.R., COLLEY, D.G., SERGENT, J.S. and DES PREZ, R.M. (1972). C3 shunt activation in human serum chelated with EGTA. J. Immunol. 109:807–809.
GOVERNA, M., VALENTINO, M., VISONA', I. and ROCCO, M. (1986). Impairment of human polymorphonuclear leukocyte chemotaxis by 2,5-hexanedione. Cell Biol. Toxicol. 2:33–39.
GOVERNA, M., VALENTINO, M. and VISONA', I. (1987). In vitro impairment of human granulocyte functions by lead. Arch. Toxicol. 59:421–425.
GOVERNA, M., VALENTINO, M. and LO MARTIRE, N., (1987). Biological reactivity of continuous glass fibers: in vitro and in vivo studies. Med. Lav. 78:190–198.
HASSELBACHER, P. AND HAHN, J.L. (1980). Activation of the alternate pathway of complement by microcrystalline cholesterol. Atherosclerosis 37:239–245.
HILL, H.R., HOGAN, N.A. and MITCHELL, T.G. (1975). Evaluation of a cytocentrifuge method for measuring neutrophil granulocyte chemotaxis. J. Lab. Clin. Med. 86:703–710.
JOHNSON, H.F. and WAGNER, J.C. (1980). A Study by electron microscopy of effects of chrysotile and man-made fibers on rat lungs. In: Biological Effects on Mineral Fibers (J.C. Wagner, ed.), pp. 293–304. IARC, Lyon.
LEHMEYER, J.E., SNYDERMAN, R. and JOHNSTON, R.B. (1979). Stimulation of neutrophil oxidative metabolism by chemotactic peptides: Influence of calcium ion concentration and cytochalasin B and comparison with stimulation by phorbol myristate acetate. Blood 54:35–45.
LEMAIRE, I. (1985). Characterization of the bronchoalveolar cellular response in experimental asbestosis. Am. Rev. Respir. Dis. 131:144–149.
MAY, J.E. and FRANK, M.M. (1973). A new complement-mediated cytolytic mechanism—The C1-bypass activation pathway. Proc. Nat. Acad. Sci. U.S.A. 70:649–652.
MOVAT, H.Z., RETTL, C., BURROWES, C.E. and JOHNSTON, M.G. (1984). The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2. Am. J. Pathol. 115:233–244.
O'FLAHERTY, J.T., KREUTZER, D.L., SHOWELL, H.J., VITKAUSKAS, G., BECKER, E.L. and WARD, P.A. (1979). Selective neutrophil desensitization to chemotactic factors. J. Cell Biol. 80:564–572.
SAINT-REMY, J.M.R. and COLE, P. (1980). Interactions of chrysotile asbestos fibres with the complement system. Immunology 41:431–437.
SANDBERG, A.L. and OSLER, A.G. (1971). Dual pathways of complement interaction with guinea pig immunoglobulins. J. Immunol. 107:1268–1273.
SELIKOFF, I.J. and LEE, D.H.K. (1978). Asbestos and Disease, pp. 135–336. Academic Press, New York.
SIMONATO, L., FLETCHER, A.C., CHERRIE, J., ANDERSEN, A., BERTAZZI, P.A., CHARNAY, N., CLAUDE, J., DODGSON, J., ESTEVE, J., FRENTZEL-BEYME, R., GARDNER, M.J., JENSEN, O.M., OLSEN, J.H., SARACCI, R., TEPPO, L., WINKELMANN, R., WESTERHOLM, P., WINTER, P.D. and ZOCCHETTI, C. (1986). The man-made mineral fiber European historical cohort study. Scand. J. Work Environ. Health 12 (Suppl. 1):34–47.
SPURNY, K.R., STUBER, H., OPIELA, H. and WEISS, G. (1979). Size-selective preparation of inorganic fibers for biological experiments. Am. Ind. Hyg. Assoc. J. 40:20–38.
TEPPO, L. and KOJONEN, E. (1986). Mortality and cancer risk among workers exposed to man-made mineral fibers in Finland. Scand. J. Work Environ. Health 12(Suppl. 1):61–64.
WEBSTER, R.O., HONG, S.R., JOHNSTON, R.B., JR. and HENSON, P.M. (1980). Biological effects of human complement fragments C5a and C5a des Argon neutrophil function. Immunopharmacology 2:201–219.
WILSON, M.R., GAUMER, H.R. and SALVAGGIO, J.E. (1977). Activation of the alternative complement pathway and generation of chemotactic factors by asbestos. J. Allergy Clin. Immunol. 60:218–222.
WHO. World Health Organization, Regional Office for Europe and International Agency for Research on Cancer (1983). Biological effects of man-made mineral fibres. Report on WHO/IARC meeting, Copenhaghen 20–22 April 1982; Copenhaghen, WHO, 1983.
WRIGHT, G. and KUSCHNER, M. (1977). The influence of varying lengths of glass and asbestos fibers on tissue response in guinea pig. In: Inhaled Particles IV (W.H. Walton, ed.), pp. 455–474. Pergamon Press, Oxford.
YANO, E., TAKEUCHI, A., YUKIYAMO, Y. and BROWN, R.C. (1984). Chemotactic factor generation by asbestos. Fibre type differences and the effects of leaching. Br. J. Exp. Path. 65:223–229.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Governa, M., Valentino, M., Visona, I. et al. Activation of the alternative complement pathway and generation of stimulating factors for granulocytes by glass fibers. Cell Biol Toxicol 4, 187–197 (1988). https://doi.org/10.1007/BF00119245
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00119245